#United States #Tampa #WindRose Health #Avalon Healthcare #Diagnostic Intelligence

Avalon Healthcare Solutions Secures Major Investment

Avalon Healthcare Solutions, a key player in Diagnostic Intelligence within the healthcare payer ecosystem, has recently announced a significant new investment. This funding, primarily sourced from WindRose Health Investors, combined with support from existing investor Francisco Partners, is set to propel Avalon into its next phase of growth and innovation.

With over 90 million members under its care, Avalon provides services to more than 30 national, regional, and community health plans through its proprietary Diagnostic Insights Platform. This platform supports the Benefit Management and Analytics services offered to its clients, alongside a patented automated policy enforcement engine (APEA) that processes more than 18 million claims monthly. This system ensures that the diagnostic care delivered is not only evidence-based but also precise and cost-effective.

Driving the Future of Diagnostics

Diagnostics are paramount in the medical field, influencing approximately 70% of clinical decisions. Despite their importance, diagnostic data has long remained underutilized. Avalon is pioneering efforts to change this by utilizing its technology platform solely designed to extract clinical and financial value from diagnostics at scale.

The new infusion of capital is expected to:

• - Expand Avalon's capabilities in Diagnostic Intelligence
• - Enhance predictive analytics and automate policy enforcement further
• - Strengthen the existing Diagnostic Insights Platform
• - Facilitate entry into new markets including Third-Party Administrators (TPAs) and Brokers for self-funded employers beginning in 2026
• - Provide greater value for health plans, healthcare providers, and their members

Commitment to Stakeholders

Avalon's operational structure will remain unchanged following this investment; no adjustments will be made to service delivery, service level agreements (SLAs), pricing, or client team configurations. The company is steadfast in its mission to unlock the full potential of diagnostic science, empowering stakeholders across the healthcare landscape with proven solutions to advance personalized care and improve patient outcomes.

Dr. Bill Kerr, CEO of Avalon, expressed enthusiasm about this development, stating, "Avalon is entering an exciting new chapter. This investment amplifies the momentum we've built and enables us to accelerate the innovation our clients rely on — from diagnostic policy automation to advanced analytics that improve outcomes across the entire test-to-treatment continuum."

David Pontius, from WindRose Health Investors, emphasized the uniqueness of Avalon's position within the diagnostics sector. He noted that, "Avalon stands at the heart of the diagnostics transformation. Their platform, clinical scientific rigor, and measurable impact make them ideally positioned to deliver substantial value across the healthcare ecosystem. We are excited to support Avalon as it scales up."

Ezra Pearlman from Francisco Partners echoed this sentiment, revealing their reinvestment reflects a strong belief in Avalon's mission and leadership. He stated, "Avalon has showcased that diagnostic intelligence is vital for fostering value-based care, and we look forward to witnessing their journey ahead."

About Avalon Healthcare Solutions

As an industry leader in diagnostic intelligence, Avalon Healthcare Solutions focuses on helping health plans and healthcare providers fully realize the benefits of diagnostic science. The company simplifies complex diagnostics, hastens the adoption of innovative approaches, and maximizes diagnostic investments. With the aid of its Diagnostic Insights Platform, Avalon integrates evidence-based policies and curated laboratory networks and delivers timely insights to enhance health outcomes—ultimately reducing costs and facilitating personalized care at scale. Supporting more than 30 health plans and over 90 million members nationwide, Avalon is dedicated to providing smarter testing, enhanced healthcare, and tangible value.

For further details, visit Avalon Healthcare Solutions.